Article Information
History
- April 5, 2024.
Article Versions
- You are currently viewing Version 1 of this article (April 5, 2024 - 13:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Emma Dann*,1,2,
- Erin Teeple*,3,
- Rasa Elmentaite2,
- Kerstin B Meyer1,
- Giorgio Gaglia3,
- Frank Nestle4,
- Virginia Savova3,
- Emanuele de Rinaldis3,+ and
- Sarah A Teichmann1,2,5,+
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- 2Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA
- 3Precision Medicine & Computational Biology, Sanofi Research US, Cambridge, MA, 01701, USA
- 4Research & Development, Sanofi, Cambridge, MA, 01701, USA
- 5Theory of Condensed Matter, Cavendish Laboratory/Dept Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, UK
- ↵+Co-Corresponding and senior authors: emanuele.derinaldis{at}sanofi.com, st9{at}sanger.ac.uk
↵* Authors contributed equally
Posted April 05, 2024.
